Correlation Between Visa and Nanhua Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Nanhua Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Nanhua Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Nanhua Bio Medicine, you can compare the effects of market volatilities on Visa and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Nanhua Bio.

Diversification Opportunities for Visa and Nanhua Bio

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Visa and Nanhua is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of Visa i.e., Visa and Nanhua Bio go up and down completely randomly.

Pair Corralation between Visa and Nanhua Bio

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.31 times more return on investment than Nanhua Bio. However, Visa Class A is 3.27 times less risky than Nanhua Bio. It trades about 0.08 of its potential returns per unit of risk. Nanhua Bio Medicine is currently generating about 0.0 per unit of risk. If you would invest  21,038  in Visa Class A on August 26, 2024 and sell it today you would earn a total of  9,954  from holding Visa Class A or generate 47.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy96.18%
ValuesDaily Returns

Visa Class A  vs.  Nanhua Bio Medicine

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Nanhua Bio Medicine 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Visa and Nanhua Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Nanhua Bio

The main advantage of trading using opposite Visa and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.
Visa vs. American Express
Visa vs. Morningstar Unconstrained Allocation
Visa vs. Sitka Gold Corp
Visa vs. MSCI ACWI exAUCONSUMER
The idea behind Visa Class A and Nanhua Bio Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Nanhua Bio vs. GigaDevice SemiconductorBeiji
Nanhua Bio vs. Puyang Huicheng Electronic
Nanhua Bio vs. Semiconductor Manufacturing Electronics
Nanhua Bio vs. Shenzhen Clou Electronics
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY